Mass spectrometric characterization of human serum albumin dimer: A new potential biomarker in chronic liver diseases
- 1 August 2015
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 112, 169-175
Abstract
No abstract availableKeywords
Funding Information
- University of Bologna
This publication has 17 references indexed in Scilit:
- Posttranscriptional changes of serum albumin: Clinical and prognostic significance in hospitalized patients with cirrhosisHepatology, 2014
- A Fast and Validated Mass Spectrometry Method for the Evaluation of Human Serum Albumin Structural Modifications in the Clinical FieldEuropean Journal of Mass Spectrometry, 2013
- Clinical indications for the albumin use: Still a controversial issueEuropean Journal of Internal Medicine, 2013
- Binding of transition metal ions to albumin: Sites, affinities and ratesBiochimica et Biophysica Acta (BBA) - General Subjects, 2013
- Human serum albumin: From bench to bedsideMolecular Aspects of Medicine, 2012
- Cys34 Adducts of Reactive Oxygen Species in Human Serum AlbuminChemical Research in Toxicology, 2012
- Characterization of cysteinylation of pharmaceutical‐grade human serum albumin by electrospray ionization mass spectrometry and low‐energy collision‐induced dissociation tandem mass spectrometryRapid Communications in Mass Spectrometry, 2005
- Heterogeneity and oxidation status of commercial human albumin preparations in clinical use*Critical Care Medicine, 2005
- AlbuminHepatology, 2005
- Review article: albumin as a drug—biological effects of albumin unrelated to oncotic pressureAlimentary Pharmacology & Therapeutics, 2002